Module 14: Oncology Precision Medicine
Course Description
This module provides participants with an overview of precision medicine in oncology. A personalized approach utilizes the unique genetic makeup of the patient and their cancer to select the safest and most effective oncology treatment regimen and supportive care plan. Upon completion of this module, pharmacists will gain a broad understanding of the impact inherited germline and acquired cancer cell genetic variations have on drug response and cancer patient outcomes.
Learning Objectives
- List the key components of the National Precision Medicine Initiative
- Identify clinically relevant germline drug-gene pairs with high levels of evidence used to predict cancer treatment toxicity or efficacy
- Select individualized treatment and supportive care regimens for cancer patients based on genetic test results
- Describe the role of the pharmacist on a multidisciplinary precision oncology team
This module includes an ACPE Pre- and Post-Test, an eLearning course, and a course evaluation. You must complete all of these module activities, in order, before claiming ACPE credits.
Presenters
Jennifer, Piccolo, PharmD, BCOP, is a Precision Medicine Pharmacist with a hematology/oncology focused practice in germline pharmacogenomics and tumor genomics at the William S. Middleton Memorial Veterans Hospital in Madison, WI, where she also serves as the Residency Program Director for the PGY2 Clinical Pharmacogenomics Program.
Dr. Piccolo received her Pharmacy Doctorate at Northeastern University in Boston, MA. Following graduation, she completed a PGY1 Pharmacy Residency at Carroll Hospital Center in Westminster, MD, and a PGY2 Oncology Pharmacy Residency at UW Health in Madison, WI. Dr. Piccolo has experience as a clinical hematology/oncology pharmacist in a variety of settings including inpatient and ambulatory, adult and pediatric, oncology, hematology, and blood and marrow transplantation, until finding a passion for applying pharmacogenomics and tumor molecular testing to improve patient care. She has completed certifications in pharmacogenomics and precision oncology. Additionally, Dr. Piccolo serves as a National Precision Oncology Program Consultant for the Veterans Health Administration where she works within an interdisciplinary team to provide recommendations for cancer treatments based on tumor molecular testing.
Carolyn J. Oxencis, PharmD, BCOP, FHOPA, is a Pharmacogenomics and Oncology Precision Medicine Pharmacist practicing at Froedtert ThedaCare Health & the Medical College of Wisconsin. She received her Doctor of Pharmacy from the University of Iowa and completed a Pharmacy Practice Residency at Froedtert Hospital in Milwaukee, WI. Dr. Oxencis is board-certified in oncology pharmacy, a Fellow of the Hematology/Oncology Pharmacy Association, and holds certifications from multiple organizations in precision medicine, pharmacogenomics, and precision oncology. She helped launch the Rare Disease and Precision Medicine Clinic at the F&MCW Cancer Center and currently oversees pharmacogenomics implementation and integration across the healthcare system while offering a virtual pharmacogenomics consult service.
Dr. Oxencis is an Associate Professor at the Medical College of Wisconsin, teaching precision medicine topics for the MCW School of Pharmacy, the Master's in Genetic Counseling program, and the Master's Precision Medicine programs. She is a founding member of the HOPA Oncology Precision Medicine Section Interest Group, an active member of the HOPA Core Competency Task Force and Oral Chemotherapy Collaborative, and previously served on the HOPA Needs Assessment, Publication, and Annual Conference Breakout Session committees. Dr. Oxencis is an active member of the Clinical Pharmacogenomics Implementation Consortium (CPIC) and the American Society of Health-System Pharmacists (ASHP), co-authoring a CPIC guideline and the ASHP Statement on the Pharmacist's Role in Clinical Pharmacogenomics. Her professional interests include precision medicine, genomics, health literacy, interprofessional education, and supportive care in oncology.
Get it here!
Knowledge Course for Pharmacists
HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
To claim ACPE Credits the learner must complete all required activities, including the pre- and post-tests, and course evaluation. CE's will be reported within 1-2 weeks of completion of the credit claim activity.
Technology requirements: HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content.